Frazier Healthcare Partners
Overview
Frazier Healthcare Partners is a private equity firm focused exclusively on the healthcare industry . Since its inception, Frazier has raised over $11 billion of capital for private funds and co-investment opportunities and has invested in more than 200 companies . Frazier has a philosophy of partnering with strong management teams while leveraging its internal operating resources and network to build exceptional companies . Frazier invests broadly across the U.S., Canada and Europe .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Vatica Health | Sep 2023 | Private Equity | Lead |
| Iolyx Therapeutics | Apr 2023 | Series A | Co-investor |
| Sudo Biosciences | Sep 2022 | Series A | Lead |
| Scout Bio | Oct 2021 | Series B | Co-investor |
| Radionetics | Oct 2021 | Seed | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.